The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Cobre Limited (ASX:CBE) has officially commenced its Q2 CY2024 drilling campaign with diamond-tipped rigs firing up on-site the company’s Botswana-based Okavango copper play.

Wholly owned by Cobre, the landholding straddles the prolific Kalahari Copper Belt (KCB).

Geotechs are going for a 2,000m program to find not only silver but any evidence of silver mineralisation that may also be present.

Drillers are hopeful they can replicate the results of a drillhole sunk in 2019 which returned intersections of “elevated copper.”

That the project is along strike from MMG’s US$1.9B Khoemacau copper project Cobre hopes can also boost its own project valuation, given silver-copper found at the former.

MMG boasts a 166Mt JORC at 2% copper and 26g/t of silver.

Cobre expects its Q2 campaign to wrap up in June.

“This phase of work forms part of the company’s strategy to advance immediate targets while progressing its in-situ copper recovery development opportunity at the Ngami Copper Project and exploring for tier 1 targets as part of the 2024 BHP Xplor programme,” Cobre CEO Adam Wooldridge said.

BHP’s (ASX:BHP) Xplor initiative sees it replicating the WA state government’s exploration incentive scheme from a private sector angle; providing funds to support exploration conducted by juniors BHP considers might be promising.

“The objective of the current programme will be to prove that anomalous copper-silver mineralisation continues into OCP demonstrating potential for new discoveries in proximity to [MMG’s landholding,]” Wooldridge added.

Cobre was one of the most hotly watched junior miner stocks through 2022.

CBE shares were up 7.4% to 5.8cps on Wednesday.

CBE by the numbers
More From The Market Online
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after